CJC-1295 + Ipamorelin

Description

• Molecular Formula: C₃₈H₄₉N₉O₅
• Molecular Weight: Approximately 711.85 g/mol
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Product Description:

CJC-1295 + Ipamorelin is a combined synthetic peptide research material containing two separately defined peptide components produced through controlled peptide synthesis. The blend is used in laboratory environments for analytical, biochemical, and experimental evaluation of multi-component peptide systems under controlled conditions. It is commonly supplied in lyophilized form to support material stability and integrity during appropriate laboratory storage and handling.

Research Applications:

CJC-1295 + Ipamorelin may be utilized in controlled laboratory research settings for applications such as:

• Analytical characterization of multi-component peptide formulations
• Investigation of peptide-receptor and molecular interaction profiles in biochemical assay systems
• Evaluation of stability and degradation behavior of combined peptide materials
• Examination of comparative and combined peptide behavior in controlled in vitro research models

Storage and Handling:

• Store the lyophilized material at -20°C or according to batch-specific supplier documentation.
• Once reconstituted, refrigerated storage at 2-8°C may be appropriate for short-term laboratory handling, subject to validated stability requirements.
• Avoid unnecessary exposure to moisture, elevated temperatures, and repeated freeze-thaw cycles.
• Use appropriate laboratory handling practices to minimize contamination and preserve material integrity.

Product Specifications:

• Purity: Refer to batch-specific HPLC results and Certificate of Analysis for each peptide component
• Appearance: Typically supplied as a lyophilized powder; verify against batch-specific documentation
• Composition: Confirm the exact ratio and quantity of CJC-1295 and Ipamorelin from the product label and COA
• Solubility: Dependent on formulation, concentration, pH, and solvent conditions; refer to supplier-specific technical documentation

Compliance Notice:

CJC-1295 + Ipamorelin is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product is supplied exclusively for controlled laboratory, analytical, and in vitro research purposes and is not intended for diagnostic, therapeutic, or clinical applications. Misuse of this product is strictly prohibited and may violate applicable federal, state, or local laws. By purchasing this product, the buyer represents and warrants that it will be used solely for legitimate laboratory research purposes.

Technical Note: A CJC-1295 + Ipamorelin blend does not have one single molecular formula, molecular weight, or amino-acid sequence because it contains two separate peptide compounds. In addition, the designation “CJC-1295” may refer to either a DAC-modified form or a non-DAC form, and these are chemically different materials. Many commercial blends use a non-DAC CJC-1295-type peptide, but you should never assume this without documentation. The final product page should therefore specify the exact CJC-1295 form, component quantities, sequences, molecular data, and analytical results exactly as listed on the supplier documentation and batch-specific Certificate of Analysis (COA).